WealthPLAN Partners’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-300
Closed -$240K 320
2020
Q2
$240K Buy
+300
New +$173K 0.02% 272
2020
Q1
Sell
-300
Closed -$281K 259
2019
Q4
$281K Buy
+300
New +$147K 0.03% 210

Other funds holding CDLX

WealthPLAN Partners's CDLX Position: Q3 2020 in Review

WealthPLAN Partners sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 300 shares — an estimated $240K sold.

WealthPLAN Partners first reported a position in CDLX in Q4 2019 and held it in 2 quarters. The position peaked at $281K in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.

  • WealthPLAN Partners reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
  • WealthPLAN Partners sold 300 Cardlytics shares in Q3 2020, an estimated $240K.
  • WealthPLAN Partners first reported a position in Cardlytics in Q4 2019 and held it in 2 quarters.
  • WealthPLAN Partners's Cardlytics position peaked at $281K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.

Based on WealthPLAN Partners's 13F filing for Q3 2020, filed 18 Dec 2020.